Posters
« Back
Altering microRNA miR-15a/16 Levels as Potential Therapy in CLL: Extrapolating from the de novo NZB Mouse Model
EP20639
Poster Title: Altering microRNA miR-15a/16 Levels as Potential Therapy in CLL: Extrapolating from the de novo NZB Mouse Model
Submitted on 20 Dec 2013
Author(s): Kasar S, Salerno E, Underbayev C, Vollenweider D, Yuan Y and Raveche E
Affiliations: University of Medicine and Dentistry of New Jersey
Poster Views: 951
View poster »


Poster Information
Abstract: Expression of miR15a/16-1 was increased using lentiviral delivery (in vitro and in vivo) or by BSAP knockdown to inhibit B-CLL malignancy.
Summary: Altering microRNA miR-15a/16 Levels as Potential Therapy in CLL: Extrapolating from the de novo NZB Mouse Model
Report abuse »
Creative Commons

Related Posters


miniaturization and automation of CEL-Seq2 and SMART-Seq2 using the mosquito liquid handler
Josip Herman1, Jon Penterman2, Sagar1, Andreas Diefenbach3, Antigoni Triantafyllopoulou4, Anne F. Hammerstein5, Joby Jenkins5, Dominic Grün1, Stuart S. Levine2 and Klaus Hentrich5

Delivery of RNP complexes for CRISPRi (dCas9) silencing in vitro and in vivo using crystalline ultrasmall particles (CUSP)
GM Unger*, VL Korman, BT Kren, DL Tobolt

Genetic Engineering in Male Sterility for Hybrid Variety Development
Abir Hasan Joy

Platinum™ II Taq Hot-Start DNA Polymerase: PCR simplified with universal annealing
Skaistė Valinskytė, Edita Elijošiūtė, Tomas Radzvilavičius, Miglė Mikutėnaitė, Jonas Belevičius, Aistė Serapinaitė, Rasa Sukackaitė

Single-use technology in the production of DNA-free Taq DNA polymerase
Kęstutis Bargaila, Vytautas, Budrys, Andrius Krasauskas, Dovilė Lisauskienė, Milda Romeikaitė, Sonata J.-Urbanavičienė, and Juozas Šiurkus